In this episode, Nathaniel Lacktman, Chair of Foley & Lardner’s national Telemedicine & Digital Health Industry Team, sits down with West Health Institute's Director of Telehealth, Michael Kurliand, and Chief Medical Officer and Executive Vice President, Dr. Zia Agha. They discuss how telehealth fits into the senior care environment and engages with patients to influence successful aging at home in America.

“The focus is on providing resources through the foundation, providing new knowledge, new models of care and evidence through the institute, and then providing information and advocacy through the policy center.”

“…there is a lot of interest and that just even our discussion around the topic, and having the implementation guide at hand, has given folks the confidence to really dig deeper into telehealth for their organization.”

“At least for virtual in PALTC, it's not, or ought not to be, about the technology, what the product is, but the environmental and situational factors, which cause PALTCs to want and should use virtual care.”

For this episode, Emily Weber, Foley Partner and member of the firm’s Health Care Industry Team, visits with Ian ONeill, General Counsel at Welltok, Inc. They will talk about the challenges of health care data, “data lakes,” how mismanaging data can impact your organization, and how to bounce back.

In this episode, Nathaniel Lacktman, Chair of Foley & Lardner’s national Telemedicine & Digital Health Industry Team, visits with Quinn Shean, Managing Director at Tusk Strategies. They discuss the current state of direct to consumer (DTC) telehealth services, advice for entrepreneurs, what makes for good asynchronous telemedicine policy, and what the virtual care industry can expect to see in 2020.

“If you're requiring that every patient interaction is going to require a video in places that have low broadband, you're furthering health inequities with a policy that you were hoping was going to broaden access.”

“The rise of DTC telehealth … is not an invasive species, but rather the result of shortcomings in the existing way that traditional healthcare is provided, and new expectations of the upcoming patient population.”

“You can take some of what you've learned from selling [other online goods] to engage patients, that type of marketing, but you better realize you're not selling mattresses and razors. Bring on a medical advisor. Build out an informal network of your medical team.”

For this episode, Jana Kolarik, Foley Health Care Attorney, visits with Angie Caldwell, Principal at PYA, to discuss fair market value and commercial reasonableness and the impact that it has on physician compensation. The conversation dives into the practical considerations that affect the analysis of fair market value and commercial reasonableness under Federal Physician Self-referral law (also known as the “Stark Law”) and the Federal Anti-kickback Statute.

For this episode, Emily Wein, Foley & Lardner LLP Telemedicine and Digital Health Attorney, visits with Rebecca Canino, Administrative Director at Johns Hopkins Health Systems Office of Telemedicine, to discuss telemedicine innovations. Johns Hopkins Medicine has six academic and community hospitals, multiple suburban health care and surgery centers, over 40 primary and specialty care practices, home care services and more. The conversation specifically addresses how telemedicine has helped clinicians at Johns Hopkins get to the “heart” of clinical care, where they are able to see patients in their own settings to enhance patient-centered care.

With Private Equity continuing its strong momentum into 2019, one area of investment that has seen huge growth is Orthopedics. In this episode of the Health Care Law Today Podcast, Roger Strode, Partner in Foley & Lardner LLP’s Health Care Industry Team discusses the evolution of Orthopedic and Spine Medicine with Dr. Todd Albert, Surgeon-in-Chief, Chief Medical Officer and Korein-Wilson Professor of Orthopedic Surgery at Hospital for Special Surgery.  This program covers the trends in Private Equity Investment in Orthopedics and what makes this specialty so attractive to investors.